World Health Organization (2023) Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 21 August 2023

Callaway E (2023) Covid’s future: mini-waves rather than seasonal surges. Nature. https://doi.org/10.1038/d41586-023-01437-8

Article  PubMed  PubMed Central  Google Scholar 

Grapsa E, Adamos G, Andrianopoulos I, Tsolaki V, Giannakoulis VG, Karavidas N, Giannopoulou V, Sarri K, Mizi E, Gavrielatou E, Papathanakos G, Mantzarlis KD, Mastora Z, Magira E, Koulouras V, Kotanidou A, Siempos II (2022) Association between vaccination status and mortality among intubated patients with covid-19-related acute respiratory distress syndrome. JAMA Netw Open 5(10):e2235219. https://doi.org/10.1001/jamanetworkopen.2022.35219

Article  PubMed  PubMed Central  Google Scholar 

Vardavas CI, Mathioudakis AG, Nikitara K, Stamatelopoulos K, Georgiopoulos G, Phalkey R, Leonardi-Bee J, Fernandez E, Carnicer-Pont D, Vestbo J, Semenza JC, Deogan C, Suk JE, Kramarz P, Lamb F, Penttinen P (2022) Prognostic factors for mortality, intensive care unit and hospital admission due to sars-cov-2: a systematic review and meta-analysis of cohort studies in europe. Eur Respir Rev 31(166):220098. https://doi.org/10.1183/16000617.0098-2022

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization (2023) Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-%282005%29-emergency-committee-regarding-the-coronavirus-disease-%28covid-19%29-pandemic. Accessed 21 August 2023

Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, Zou J, Cai J, Liu H, Wang Y, Wang T, Tian Y, Zheng N, Yan X, Sun R, Xu X, Zhou X, Ge S, Liang Y, Yi L, Yang J, Zhang J, Ajelli M, Yu H (2022) Epidemiological characteristics and transmission dynamics of the outbreak caused by the sars-cov-2 omicron variant in shanghai, china: A descriptive study. Lancet Reg Health West Pac 29(100592):100592. https://doi.org/10.1016/j.lanwpc.2022.100592

Article  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control and Prevention (2023) Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html. Accessed 21 August 2023

Cari L, Naghavi Alhosseini M, Bergamo A, Pacor S, Pierno S, Sava G, Nocentini G (2022) Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based covid-19 vaccines. Front Cardiovasc Med 9:967926. https://doi.org/10.3389/fcvm.2022.967926

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrera-Comoglio R, Lane S (2022) Vaccine-induced immune thrombocytopenia and thrombosis after the sputnik V vaccine. N Engl J Med 387(15):1431–1432. https://doi.org/10.1056/NEJMc2210813

Article  PubMed  Google Scholar 

Lotti E, Masi A, Cappugi C, Fanelli A, Mannini L, Marcucci R, Poli D (2022) Anti-sars-cov-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatment. Blood Transfus 20(5):433–436. https://doi.org/10.2450/2022.0271-21

Article  PubMed  PubMed Central  Google Scholar 

Carroll DN, Carroll DG (2009) Fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. Ann Pharmacother 43(4):754–760. https://doi.org/10.1345/aph.1L413

Article  CAS  PubMed  Google Scholar 

Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini GF, Prisco D (2002) Need of more frequent international normalized ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis 13(4):297–300. https://doi.org/10.1097/00001721-200206000-00004

Article  CAS  PubMed  Google Scholar 

Chen L, Zhou YZ, Zhou XM, Liu LM, Xu P, Zhang X, Tan SL (2021) Evaluation of the safe multidisciplinary app-assisted remote patient-self-testing (smart) model for warfarin home management during the covid-19 pandemic: study protocol of a multi-center randomized controlled trial. BMC Health Serv Res 21(1):875. https://doi.org/10.1186/s12913-021-06882-7

Article  PubMed  PubMed Central  Google Scholar 

Aomori T, Yamamoto K, Oguchi-Katayama A, Kawai Y, Ishidao T, Mitani Y, Kogo Y, Lezhava A, Fujita Y, Obayashi K, Nakamura K, Kohnke H, Wadelius M, Ekström L, Skogastierna C, Rane A, Kurabayashi M, Murakami M, Cizdziel PE, Hayashizaki Y, Horiuchi R (2009) Rapid single-nucleotide polymorphism detection of cytochrome p450 (cyp2c9) and vitamin K epoxide reductase (vkorc1) genes for the warfarin dose adjustment by the smart-amplification process version 2. Clin Chem 55(4):804–812. https://doi.org/10.1373/clinchem.2008.115295

Article  CAS  PubMed  Google Scholar 

Tan SL, Li Z, Zhang W, Song GB, Liu LM, Peng J, Liu ZQ, Fan L, Meng XG, Wang LS, Chen Y, Zhou XM, Zhou HH (2013) Cytochrome p450 oxidoreductase genetic polymorphisms a503V and rs2868177 do not significantly affect warfarin stable dosage in Han-chinese patients with mechanical heart valve replacement. Eur J Clin Pharmacol 69(10):1769–1775. https://doi.org/10.1007/s00228-013-1544-2

Article  CAS  PubMed  Google Scholar 

Mannering GJ, Renton KW, el Azhary R, Deloria LB (1980) Effects of interferon-inducing agents on hepatic cytochrome p-450 drug metabolizing systems. Ann N Y Acad Sci 350:314–331. https://doi.org/10.1111/j.1749-6632.1980.tb20631.x

Article  CAS  PubMed  Google Scholar 

Kramer P, McClain CJ (1981) Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 305(21):1262–1264. https://doi.org/10.1056/NEJM198111193052106

Article  CAS  PubMed  Google Scholar 

Renton KW, Gray JD, Hall RI (1980) Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 123(4):288–290

CAS  PubMed  PubMed Central  Google Scholar 

Campello E, Bulato C, Simion C, Spiezia L, Radu CM, Gavasso S, Sartorello F, Saggiorato G, Zerbinati P, Fadin M, Tormene D, Simioni P (2022) Assessing clinically meaningful hypercoagulability after covid-19 vaccination: a longitudinal study. Thromb Haemost 122(8):1352–1360. https://doi.org/10.1055/a-1788-5206

Article  PubMed  PubMed Central  Google Scholar 

Farrow PR, Nicholson KG (1984) Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin. J Infect 9(2):157–160. https://doi.org/10.1016/s0163-4453(84)91156-3

Article  CAS  PubMed  Google Scholar 

Lipsky BA, Pecoraro RE, Roben NJ, de Blaquiere P, Delaney CJ (1984) Influenza vaccination and warfarin anticoagulation. Ann Intern Med 100(6):835–837. https://doi.org/10.7326/0003-4819-100-6-835

Article  CAS  PubMed  Google Scholar 

Gomolin IH (1986) Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly. CMAJ 135(1):39–41

CAS  PubMed  PubMed Central  Google Scholar 

Iorio A, Basileo M, Marcucci M, Guercini F, Camilloni B, Paccamiccio E, Vecchioli M, Iorio AM (2010) Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. Arch Intern Med 170(7):609–616. https://doi.org/10.1001/archinternmed.2010.49

Article  CAS  PubMed  Google Scholar 

Yin T, Miyata T (2007) Warfarin dose and the pharmacogenomics of cyp2c9 and vkorc1 - rationale and perspectives. Thromb Res 120(1):1–10. https://doi.org/10.1016/j.thromres.2006.10.021

Article  CAS  PubMed  Google Scholar 

Yang J, Chen Y, Li X, Wei X, Chen X, Zhang L, Zhang Y, Xu Q, Wang H, Li Y, Lu C, Chen W, Zeng C, Yin T (2013) Influence of cyp2c9 and vkorc1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis. Int J Cardiol 168(4):4234–4243. https://doi.org/10.1016/j.ijcard.2013.07.151

Article  PubMed  Google Scholar 

van Heteren DM, Lijfering WM, van der Meer F, Reitsma PH, Swen JJ, Bos M, van Rein N (2023) Association of vkorc1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists. J Intern Med 293(1):124–127. https://doi.org/10.1111/joim.13569

Article  CAS  PubMed  Google Scholar 

Wang L, Liu L, Liu X, Xiang M, Zhou L, Huang C, Shen Z, Miao L (2020) The gut microbes, enterococcus and escherichia-shigella, affect the responses of heart valve replacement patients to the anticoagulant warfarin. Pharmacol Res 159:104979. https://doi.org/10.1016/j.phrs.2020.104979

Article  CAS  PubMed  Google Scholar 

Chen W, Qian J, Fu J, Wu T, Lv M, Jiang S, Zhang J (2022) Changes in the gut microbiota may affect the clinical efficacy of oral anticoagulants. Front Pharmacol 13:860237. https://doi.org/10.3389/fphar.2022.860237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giuliano V, Bassotti G, Mourvaki E, Castellani D, Filippucci E, Sabatino G, Gizzi S, Palmerini F, Galli F, Morelli O, Baldoni M, Morelli A, Iorio A (2010) Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res 126(1):12–17. https://doi.org/10.1016/j.thromres.2009.11.032

Article  CAS  PubMed  Google Scholar 

Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF (2021) Safety and immunogenicity of a recombinant tandem-repeat dimeric rbd-based protein subunit vaccine (zf2001) against covid-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis 21(8):1107–1119. https://doi.org/10.1016/S1473-3099(21)00127-4

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F (2021) Safety, tolerability, and immunogenicity of an inactivated sars-cov-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 21(2):181–192. https://doi.org/10.1016/S1473-3099(20)30843-4

Article  CAS  PubMed  Google Scholar 

Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W (2021) Safety, tolerability, and immunogenicity of an inactivated sars-cov-2 vaccine (coronavac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 21(6):803–812. https://doi.org/10.1016/S1473-3099(20)30987-7